CHARMY PATEL NP
Prescription History 1013451921
Nurse Practitioner - Family in Dracut, MA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for CHARMY PATEL NP, an active Family specialist practicing in Dracut, MA. Our medical registry currently tracks 54 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 3,139 documented patient claims. Among these therapy options, the most frequently utilized medication is Ozempic, which accounts for 286 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MA PrescribersVs. MA Avg |
|---|---|---|---|
| OzempicSemaglutide | 286 | $1,567.69 | ▲ More than typical |
About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT. In 2024, this provider wrote 286 Medicare prescriptions for Ozempic, about 5.6 times the volume of the typical Massachusetts prescriber of this medication (50.9). Medicare paid an average of $1,567.69 per fill, versus $1,217.01 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 485.8 30-Day Fills standardized to 30-day supplies 14,270 Days of Medication total across all patients in 2024 | |||
| Metformin Hcl ErMetformin Hcl | 221 | $14.11 | ▲ More than typical |
About Metformin Hcl Er: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2024, this provider wrote 221 Medicare prescriptions for Metformin Hcl Er, about 4.3 times the volume of the typical Massachusetts prescriber of this medication (51.5). Medicare paid an average of $14.11 per fill, versus $12.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 534.6 30-Day Fills standardized to 30-day supplies 15,972 Days of Medication total across all patients in 2024 | |||
| Metformin Hcl | 217 | $9.81 | ▲ More than typical |
About Metformin Hcl: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2024, this provider wrote 217 Medicare prescriptions for Metformin Hcl, about 3 times the volume of the typical Massachusetts prescriber of this medication (72.6). Medicare paid an average of $9.81 per fill, versus $9.67 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 493.8 30-Day Fills standardized to 30-day supplies 14,746 Days of Medication total across all patients in 2024 | |||
| MounjaroTirzepatide | 167 | $1,288.38 | ▲ More than typical |
About Mounjaro: Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes. An analog of GASTRIC INHIBITORY POLYPEPTIDE and agonist of GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR and GLUCAGON-LIKE PEPTIDE-1 RECEPTOR used to enhance glycemic control of TYPE 2 DIABETES MELLITUS. In 2024, this provider wrote 167 Medicare prescriptions for Mounjaro, about 3.6 times the volume of the typical Massachusetts prescriber of this medication (46.1). Medicare paid an average of $1,288.38 per fill, versus $1,225.06 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 203.9 30-Day Fills standardized to 30-day supplies 5,832 Days of Medication total across all patients in 2024 | |||
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 159 | $101.96 | ▲ More than typical |
In 2024, this provider wrote 159 Medicare prescriptions for Nano 2nd Gen Pen Needle, about 3.8 times the volume of the typical Massachusetts prescriber of this medication (41.3). Medicare paid an average of $101.96 per fill, versus $95.64 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 422.7 30-Day Fills standardized to 30-day supplies 12,647 Days of Medication total across all patients in 2024 | |||
| JardianceEmpagliflozin | 156 | $1,225.52 | ▲ More than typical |
About Jardiance: Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure and kidney disease. It helps to lower the risk of death from heart disease and reduces the need of going to a hospital to treat heart failure or kidney disease. It also helps to lower the risk of dialysis in people with kidney disease. Empagliflozin works by increasing the removal of sodium by your kidneys. In 2024, this provider wrote 156 Medicare prescriptions for Jardiance, about 3.2 times the volume of the typical Massachusetts prescriber of this medication (49.3). Medicare paid an average of $1,225.52 per fill, versus $1,010.43 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 337.5 30-Day Fills standardized to 30-day supplies 10,061 Days of Medication total across all patients in 2024 | |||
| TrulicityDulaglutide | 123 | $1,230.35 | ▲ More than typical |
About Trulicity: Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment. A glucagon-like peptide-1 receptor agonist; GLP-1 immunoglobulin G (IgG4) Fc fusion protein with extended activity. In 2024, this provider wrote 123 Medicare prescriptions for Trulicity, about 2.5 times the volume of the typical Massachusetts prescriber of this medication (49.1). Medicare paid an average of $1,230.35 per fill, versus $1,207.77 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 158.1 30-Day Fills standardized to 30-day supplies 4,552 Days of Medication total across all patients in 2024 | |||
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 117 | $924.01▼ below MA avg | ▲ More than typical |
About Toujeo Max Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2024, this provider wrote 117 Medicare prescriptions for Toujeo Max Solostar, about 5 times the volume of the typical Massachusetts prescriber of this medication (23.2). Medicare paid an average of $924.01 per fill, versus $1,147.39 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 281.7 30-Day Fills standardized to 30-day supplies 8,449 Days of Medication total across all patients in 2024 | |||
| Humalog Mix 50-50 KwikpenInsulin Lispro Protamin/Lispro | 104 | $364.70▼ below MA avg | ▲ More than typical |
About Humalog Mix 50-50 Kwikpen: Insulin lispro protamine/insulin lispro is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ This product is a combination of two man-made insulins: intermediate-acting insulin lispro protamine and rapid-acting insulin lispro. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. In 2024, this provider wrote 104 Medicare prescriptions for Humalog Mix 50-50 Kwikpen, about 2.6 times the volume of the typical Massachusetts prescriber of this medication (40.4). Medicare paid an average of $364.70 per fill, versus $380.38 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 184.9 30-Day Fills standardized to 30-day supplies 5,504 Days of Medication total across all patients in 2024 | |||
| Atorvastatin Calcium | 92 | $17.02 | ▼ Less than typical |
About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. In 2024, this provider wrote 92 Medicare prescriptions for Atorvastatin Calcium, about half the volume of the typical Massachusetts prescriber of this medication (188). Medicare paid an average of $17.02 per fill, versus $13.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 230 30-Day Fills standardized to 30-day supplies 6,857 Days of Medication total across all patients in 2024 | |||
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 88 | $227.32▼ below MA avg | ▲ More than typical |
About Novolog Mix 70-30 Flexpen: Insulin aspart protamine/insulin aspart is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ This product is a combination of two man-made insulins: intermediate-acting insulin aspart protamine and rapid-acting insulin aspart. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. In 2024, this provider wrote 88 Medicare prescriptions for Novolog Mix 70-30 Flexpen, about 3.3 times the volume of the typical Massachusetts prescriber of this medication (26.9). Medicare paid an average of $227.32 per fill, versus $295.08 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 142.5 30-Day Fills standardized to 30-day supplies 4,145 Days of Medication total across all patients in 2024 | |||
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 82 | $127.76 | ▲ More than typical |
About Lantus Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-aglr, and insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2024, this provider wrote 82 Medicare prescriptions for Lantus Solostar, about 2 times the volume of the typical Massachusetts prescriber of this medication (40). Medicare paid an average of $127.76 per fill, versus $121.42 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 217.2 30-Day Fills standardized to 30-day supplies 6,515 Days of Medication total across all patients in 2024 | |||
| Tresiba Flextouch U-200Insulin Degludec | 79 | $1,137.14 | ▲ More than typical |
About Tresiba Flextouch U-200: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2024, this provider wrote 79 Medicare prescriptions for Tresiba Flextouch U-200, about 2.6 times the volume of the typical Massachusetts prescriber of this medication (30.2). Medicare paid an average of $1,137.14 per fill, versus $1,129.37 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 197.2 30-Day Fills standardized to 30-day supplies 5,914 Days of Medication total across all patients in 2024 | |||
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 69 | $96.44 | ▲ More than typical |
In 2024, this provider wrote 69 Medicare prescriptions for Ultra-Fine Mini Pen Needle, about 2.6 times the volume of the typical Massachusetts prescriber of this medication (26.3). Medicare paid an average of $96.44 per fill, versus $91.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 193.1 30-Day Fills standardized to 30-day supplies 5,788 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 65 | $13.72▼ below MA avg | ≈ Typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 65 Medicare prescriptions for Gabapentin, about 81% of the volume of the typical Massachusetts prescriber of this medication (80.5). Medicare paid an average of $13.72 per fill, versus $14.49 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 130.8 30-Day Fills standardized to 30-day supplies 3,905 Days of Medication total across all patients in 2024 | |||
| Glipizide ErGlipizide | 54 | $13.52▼ below MA avg | ▲ More than typical |
About Glipizide Er: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. In 2024, this provider wrote 54 Medicare prescriptions for Glipizide Er, about 1.6 times the volume of the typical Massachusetts prescriber of this medication (34.2). Medicare paid an average of $13.52 per fill, versus $17.43 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 116.3 30-Day Fills standardized to 30-day supplies 3,489 Days of Medication total across all patients in 2024 | |||
| Levothyroxine Sodium | 45 | $11.72 | ▼ Less than typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2024, this provider wrote 45 Medicare prescriptions for Levothyroxine Sodium, about a third of the volume of the typical Massachusetts prescriber of this medication (122.8). Medicare paid an average of $11.72 per fill, versus $10.45 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 123 30-Day Fills standardized to 30-day supplies 3,690 Days of Medication total across all patients in 2024 | |||
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 45 | $449.83 | ▲ More than typical |
About Basaglar Kwikpen U-100: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-aglr, and insulin glargine-yfgn. In 2024, this provider wrote 45 Medicare prescriptions for Basaglar Kwikpen U-100, about 1.5 times the volume of the typical Massachusetts prescriber of this medication (31). Medicare paid an average of $449.83 per fill, versus $412.05 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 87.6 30-Day Fills standardized to 30-day supplies 2,598 Days of Medication total across all patients in 2024 | |||
| Glimepiride | 45 | $9.23▼ below MA avg | ▲ More than typical |
About Glimepiride: Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. In 2024, this provider wrote 45 Medicare prescriptions for Glimepiride, about 1.4 times the volume of the typical Massachusetts prescriber of this medication (31.7). Medicare paid an average of $9.23 per fill, versus $10.08 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 127 30-Day Fills standardized to 30-day supplies 3,811 Days of Medication total across all patients in 2024 | |||
| Tresiba Flextouch U-100Insulin Degludec | 44 | $589.14▼ below MA avg | ▲ More than typical |
About Tresiba Flextouch U-100: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2024, this provider wrote 44 Medicare prescriptions for Tresiba Flextouch U-100, about 1.3 times the volume of the typical Massachusetts prescriber of this medication (34.3). Medicare paid an average of $589.14 per fill, versus $644.36 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 99.6 30-Day Fills standardized to 30-day supplies 2,989 Days of Medication total across all patients in 2024 | |||
| FarxigaDapagliflozin Propanediol | 42 | $1,230.63 | ≈ Typical |
About Farxiga: Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sugar by your kidneys. Dapagliflozin is also used to treat kidney disease and heart failure. It helps to lower the risk of death from heart disease and reduces the need of going to a doctor or hospital to treat heart failure. Dapagliflozin works by increasing the removal of sodium by your kidneys. In 2024, this provider wrote 42 Medicare prescriptions for Farxiga, about the same volume as the typical Massachusetts prescriber of this medication (38). Medicare paid an average of $1,230.63 per fill, versus $908.11 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 92.9 30-Day Fills standardized to 30-day supplies 2,787 Days of Medication total across all patients in 2024 | |||
| TradjentaLinagliptin | 42 | $678.50 | ▲ More than typical |
About Tradjenta: Linagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used by people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Linagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS. In 2024, this provider wrote 42 Medicare prescriptions for Tradjenta, about 1.4 times the volume of the typical Massachusetts prescriber of this medication (30.8). Medicare paid an average of $678.50 per fill, versus $635.39 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 54 30-Day Fills standardized to 30-day supplies 1,620 Days of Medication total across all patients in 2024 | |||
| Rosuvastatin Calcium | 42 | $31.33 | ▼ Less than typical |
About Rosuvastatin Calcium: Rosuvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. In addition to eating a proper diet (such as a low cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Talk with your doctor for more details. A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES. In 2024, this provider wrote 42 Medicare prescriptions for Rosuvastatin Calcium, about half the volume of the typical Massachusetts prescriber of this medication (79.3). Medicare paid an average of $31.33 per fill, versus $28.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 106.7 30-Day Fills standardized to 30-day supplies 3,192 Days of Medication total across all patients in 2024 | |||
| Alcohol Prep PadsAlcohol Antiseptic Pads | 40 | $11.64▼ below MA avg | ▲ More than typical |
In 2024, this provider wrote 40 Medicare prescriptions for Alcohol Prep Pads, about 1.6 times the volume of the typical Massachusetts prescriber of this medication (25.1). Medicare paid an average of $11.64 per fill, versus $19.54 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 92.7 30-Day Fills standardized to 30-day supplies 2,730 Days of Medication total across all patients in 2024 | |||
| Humalog Kwikpen U-100Insulin Lispro | 40 | $380.87 | ≈ Typical |
About Humalog Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2024, this provider wrote 40 Medicare prescriptions for Humalog Kwikpen U-100, about 1.2 times the volume of the typical Massachusetts prescriber of this medication (34.2). Medicare paid an average of $380.87 per fill, versus $252.24 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 101.6 30-Day Fills standardized to 30-day supplies 3,038 Days of Medication total across all patients in 2024 | |||
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 40 | $95.00 | ▲ More than typical |
In 2024, this provider wrote 40 Medicare prescriptions for Ultra-Fine Nano Pen Needle, about 1.9 times the volume of the typical Massachusetts prescriber of this medication (20.6). Medicare paid an average of $95.00 per fill, versus $84.25 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 89 30-Day Fills standardized to 30-day supplies 2,600 Days of Medication total across all patients in 2024 | |||
| Repaglinide | 39 | $37.33 | ▲ More than typical |
About Repaglinide: Repaglinide is used alone or with other medications to control high blood sugar along with a proper diet and exercise program. Show more ▾ It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. It works by stimulating the body to produce more insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. In 2024, this provider wrote 39 Medicare prescriptions for Repaglinide, about 1.3 times the volume of the typical Massachusetts prescriber of this medication (29.4). Medicare paid an average of $37.33 per fill, versus $32.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 106.5 30-Day Fills standardized to 30-day supplies 3,195 Days of Medication total across all patients in 2024 | |||
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 39 | $658.48▼ below MA avg | ▲ More than typical |
About Toujeo Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2024, this provider wrote 39 Medicare prescriptions for Toujeo Solostar, about 1.7 times the volume of the typical Massachusetts prescriber of this medication (23.2). Medicare paid an average of $658.48 per fill, versus $737.27 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 95.6 30-Day Fills standardized to 30-day supplies 2,862 Days of Medication total across all patients in 2024 | |||
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 36 | $65.33▼ below MA avg | ▲ More than typical |
In 2024, this provider wrote 36 Medicare prescriptions for Ultra-Fine Short Pen Needle, about 1.3 times the volume of the typical Massachusetts prescriber of this medication (27.3). Medicare paid an average of $65.33 per fill, versus $90.61 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 94.5 30-Day Fills standardized to 30-day supplies 2,835 Days of Medication total across all patients in 2024 | |||
| HumalogInsulin Lispro | 33 | $349.73 | ≈ Typical |
About Humalog: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2024, this provider wrote 33 Medicare prescriptions for Humalog, about the same volume as the typical Massachusetts prescriber of this medication (29.2). Medicare paid an average of $349.73 per fill, versus $177.25 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 67.8 30-Day Fills standardized to 30-day supplies 2,033 Days of Medication total across all patients in 2024 | |||
| Alcohol PadsAlcohol Antiseptic Pads | 33 | $51.05 | ▲ More than typical |
In 2024, this provider wrote 33 Medicare prescriptions for Alcohol Pads, about 1.6 times the volume of the typical Massachusetts prescriber of this medication (20.8). Medicare paid an average of $51.05 per fill, versus $49.13 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 42.3 30-Day Fills standardized to 30-day supplies 1,159 Days of Medication total across all patients in 2024 | |||
| Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro | 31 | $311.53▼ below MA avg | ▲ More than typical |
About Humalog Mix 75-25 Kwikpen: Insulin lispro protamine/insulin lispro is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ This product is a combination of two man-made insulins: intermediate-acting insulin lispro protamine and rapid-acting insulin lispro. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. In 2024, this provider wrote 31 Medicare prescriptions for Humalog Mix 75-25 Kwikpen, about 1.3 times the volume of the typical Massachusetts prescriber of this medication (24.1). Medicare paid an average of $311.53 per fill, versus $351.57 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 49.5 30-Day Fills standardized to 30-day supplies 1,460 Days of Medication total across all patients in 2024 | |||
| Losartan Potassium | 30 | $11.46▼ below MA avg | ▼ Less than typical |
About Losartan Potassium: Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. Show more ▾ It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Losartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily. An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II. In 2024, this provider wrote 30 Medicare prescriptions for Losartan Potassium, about a third of the volume of the typical Massachusetts prescriber of this medication (89.9). Medicare paid an average of $11.46 per fill, versus $11.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 60 30-Day Fills standardized to 30-day supplies 1,760 Days of Medication total across all patients in 2024 | |||
| Gvoke Hypopen 2-PackGlucagon | 30 | $770.44 | ▲ More than typical |
About Gvoke Hypopen 2-Pack: This medication is the same as your body's own glucagon, a natural substance that raises blood sugar by causing the body to release sugar stored in the liver. Show more ▾ It is used to treat very low blood sugar (hypoglycemia) that may cause you to need help from others. Make sure a family member or caregiver knows where you keep this medication and how to use it before you need help. A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) In 2024, this provider wrote 30 Medicare prescriptions for Gvoke Hypopen 2-Pack, about 1.4 times the volume of the typical Massachusetts prescriber of this medication (21.6). Medicare paid an average of $770.44 per fill, versus $679.54 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39.3 30-Day Fills standardized to 30-day supplies 721 Days of Medication total across all patients in 2024 | |||
| Lisinopril | 26 | $7.04▼ below MA avg | ▼ Less than typical |
About Lisinopril: Lisinopril is used to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily. One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure. In 2024, this provider wrote 26 Medicare prescriptions for Lisinopril, about a quarter of the volume of the typical Massachusetts prescriber of this medication (123.3). Medicare paid an average of $7.04 per fill, versus $8.13 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 73.7 30-Day Fills standardized to 30-day supplies 2,212 Days of Medication total across all patients in 2024 | |||
| Insulin Lispro Kwikpen U-100Insulin Lispro | 26 | $185.14 | ≈ Typical |
About Insulin Lispro Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2024, this provider wrote 26 Medicare prescriptions for Insulin Lispro Kwikpen U-100, about the same volume as the typical Massachusetts prescriber of this medication (24.5). Medicare paid an average of $185.14 per fill, versus $159.28 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32.7 30-Day Fills standardized to 30-day supplies 844 Days of Medication total across all patients in 2024 | |||
| Pravastatin Sodium | 25 | $19.16▼ below MA avg | ▼ Less than typical |
About Pravastatin Sodium: Pravastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES). In 2024, this provider wrote 25 Medicare prescriptions for Pravastatin Sodium, about half the volume of the typical Massachusetts prescriber of this medication (45.4). Medicare paid an average of $19.16 per fill, versus $19.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 54.8 30-Day Fills standardized to 30-day supplies 1,620 Days of Medication total across all patients in 2024 | |||
| Metoprolol Succinate | 24 | $9.47▼ below MA avg | ▼ Less than typical |
About Metoprolol Succinate: This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart. A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. In 2024, this provider wrote 24 Medicare prescriptions for Metoprolol Succinate, about a quarter of the volume of the typical Massachusetts prescriber of this medication (112.2). Medicare paid an average of $9.47 per fill, versus $18.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 34 30-Day Fills standardized to 30-day supplies 986 Days of Medication total across all patients in 2024 | |||
| Novolog FlexpenInsulin Aspart | 23 | $267.59 | ▼ Less than typical |
About Novolog Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2024, this provider wrote 23 Medicare prescriptions for Novolog Flexpen, about 69% of the volume of the typical Massachusetts prescriber of this medication (33.4). Medicare paid an average of $267.59 per fill, versus $217.45 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 40 30-Day Fills standardized to 30-day supplies 1,197 Days of Medication total across all patients in 2024 | |||
| Pioglitazone Hcl | 23 | $12.86▼ below MA avg | ≈ Typical |
About Pioglitazone Hcl: Pioglitazone is a diabetes drug (thiazolidinedione-type, also called "glitazones") used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. Show more ▾ It works by helping to restore your body's proper response to insulin, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone is used either alone or in combination with other diabetes medications (such as metformin or a sulfonylurea such as glyburide). Talk to your doctor about the risks and benefits of pioglitazone. A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS. In 2024, this provider wrote 23 Medicare prescriptions for Pioglitazone Hcl, about 81% of the volume of the typical Massachusetts prescriber of this medication (28.4). Medicare paid an average of $12.86 per fill, versus $17.28 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 51 30-Day Fills standardized to 30-day supplies 1,530 Days of Medication total across all patients in 2024 | |||
| Humulin R U-500 KwikpenInsulin Regular, Human | 23 | $2,101.64 | ≈ Typical |
About Humulin R U-500 Kwikpen: Concentrated insulin regular is used with a proper diet and exercise program to control high blood sugar in people with diabetes who require large doses of insulin (more than 200 units per day). Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It works right away like regular insulin but its effects last longer. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication may be used alone or with other oral diabetes drugs (such as metformin). Regular insulin preparations that contain the HUMAN insulin peptide sequence. In 2024, this provider wrote 23 Medicare prescriptions for Humulin R U-500 Kwikpen, about 84% of the volume of the typical Massachusetts prescriber of this medication (27.3). Medicare paid an average of $2,101.64 per fill, versus $1,611.82 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34.9 30-Day Fills standardized to 30-day supplies 966 Days of Medication total across all patients in 2024 | |||
| Pregabalin | 22 | $6.22▼ below MA avg | ▼ Less than typical |
About Pregabalin: This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. Show more ▾ This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures). A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA. In 2024, this provider wrote 22 Medicare prescriptions for Pregabalin, about 65% of the volume of the typical Massachusetts prescriber of this medication (33.8). Medicare paid an average of $6.22 per fill, versus $26.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 31 30-Day Fills standardized to 30-day supplies 886 Days of Medication total across all patients in 2024 | |||
| JanuviaSitagliptin Phosphate | 20 | $1,230.01 | ▼ Less than typical |
About Januvia: Sitagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Sitagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES. In 2024, this provider wrote 20 Medicare prescriptions for Januvia, about half the volume of the typical Massachusetts prescriber of this medication (33.5). Medicare paid an average of $1,230.01 per fill, versus $854.42 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 46 30-Day Fills standardized to 30-day supplies 1,362 Days of Medication total across all patients in 2024 | |||
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 18 | $1,453.31 | ▼ Less than typical |
About Fiasp Flextouch: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. In 2024, this provider wrote 18 Medicare prescriptions for Fiasp Flextouch, about 64% of the volume of the typical Massachusetts prescriber of this medication (28). Medicare paid an average of $1,453.31 per fill, versus $867.45 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30.6 30-Day Fills standardized to 30-day supplies 889 Days of Medication total across all patients in 2024 | |||
| Alcohol SwabsAlcohol Antiseptic Pads | 16 | $12.56 | ▼ Less than typical |
In 2024, this provider wrote 16 Medicare prescriptions for Alcohol Swabs, about half the volume of the typical Massachusetts prescriber of this medication (28). Medicare paid an average of $12.56 per fill, versus $6.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30.7 30-Day Fills standardized to 30-day supplies 920 Days of Medication total across all patients in 2024 | |||
| Comfort Ez Pen NeedlePen Needle, Diabetic | 16 | $146.59 | ≈ Typical |
In 2024, this provider wrote 16 Medicare prescriptions for Comfort Ez Pen Needle, about the same volume as the typical Massachusetts prescriber of this medication (17.7). Medicare paid an average of $146.59 per fill, versus $93.70 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28.4 30-Day Fills standardized to 30-day supplies 837 Days of Medication total across all patients in 2024 | |||
| Ulticare Pen NeedlePen Needle, Diabetic | 15 | $58.98▼ below MA avg | ≈ Typical |
In 2024, this provider wrote 15 Medicare prescriptions for Ulticare Pen Needle, about 81% of the volume of the typical Massachusetts prescriber of this medication (18.5). Medicare paid an average of $58.98 per fill, versus $62.97 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 20.7 30-Day Fills standardized to 30-day supplies 620 Days of Medication total across all patients in 2024 | |||
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 15 | $1,329.15▼ below MA avg | ▼ Less than typical |
About Xultophy 100-3.6: This medication is a combination of insulin degludec and liraglutide and is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Liraglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high sugar levels (such as after a meal) and decreasing the amount of sugar your liver makes. In 2024, this provider wrote 15 Medicare prescriptions for Xultophy 100-3.6, about half the volume of the typical Massachusetts prescriber of this medication (26.1). Medicare paid an average of $1,329.15 per fill, versus $1,862.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 34.3 30-Day Fills standardized to 30-day supplies 1,030 Days of Medication total across all patients in 2024 | |||
| Gemfibrozil | 13 | $5.23▼ below MA avg | ▼ Less than typical |
About Gemfibrozil: Gemfibrozil is used along with a proper diet to help lower fats (triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾ It may also help to lower "bad" cholesterol (LDL). Gemfibrozil belongs to a group of drugs known as "fibrates." It works by decreasing the amount of fat produced by the liver. Lowering triglycerides in people with very high triglyceride blood levels may decrease the risk of pancreas disease (pancreatitis). However, gemfibrozil might not lower your risk of a heart attack or stroke. Talk to your doctor about the risk and benefits of gemfibrozil. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, drinking less alcohol, losing weight if overweight, and stopping smoking. A lipid-regulating agent that lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol. In 2024, this provider wrote 13 Medicare prescriptions for Gemfibrozil, about 63% of the volume of the typical Massachusetts prescriber of this medication (20.5). Medicare paid an average of $5.23 per fill, versus $21.81 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
| Glipizide | 13 | $16.90 | ▼ Less than typical |
About Glipizide: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. In 2024, this provider wrote 13 Medicare prescriptions for Glipizide, about a third of the volume of the typical Massachusetts prescriber of this medication (33.2). Medicare paid an average of $16.90 per fill, versus $10.70 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2024 | |||
| RybelsusSemaglutide | 12 | $1,462.89 | ▼ Less than typical |
About Rybelsus: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT. In 2024, this provider wrote 12 Medicare prescriptions for Rybelsus, about half the volume of the typical Massachusetts prescriber of this medication (22.7). Medicare paid an average of $1,462.89 per fill, versus $1,400.76 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| Humulin N KwikpenInsulin Nph Human Isophane | 12 | $188.13▼ below MA avg | ▼ Less than typical |
About Humulin N Kwikpen: Insulin isophane is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is an intermediate-acting insulin (isophane). It starts to work more slowly but lasts longer than regular insulin. Insulin isophane works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin isophane is often used in combination with a shorter-acting insulin. It may also be used alone or with other oral diabetes drugs (such as metformin). In 2024, this provider wrote 12 Medicare prescriptions for Humulin N Kwikpen, about 64% of the volume of the typical Massachusetts prescriber of this medication (18.8). Medicare paid an average of $188.13 per fill, versus $207.90 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 31 30-Day Fills standardized to 30-day supplies 910 Days of Medication total across all patients in 2024 | |||
| Ultra-Fine Micro Pen NeedlePen Needle, Diabetic | 11 | $119.08 | ▼ Less than typical |
In 2024, this provider wrote 11 Medicare prescriptions for Ultra-Fine Micro Pen Needle, about 62% of the volume of the typical Massachusetts prescriber of this medication (17.7). Medicare paid an average of $119.08 per fill, versus $100.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28 30-Day Fills standardized to 30-day supplies 840 Days of Medication total across all patients in 2024 | |||
| Easy Touch Alcohol Prep PadsAlcohol Antiseptic Pads | 11 | $5.11 | ▼ Less than typical |
In 2024, this provider wrote 11 Medicare prescriptions for Easy Touch Alcohol Prep Pads, about 64% of the volume of the typical Massachusetts prescriber of this medication (17.3). Medicare paid an average of $5.11 per fill, versus $5.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17.8 30-Day Fills standardized to 30-day supplies 534 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for CHARMY PATEL NP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Dracut, MA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
